Professional Summary
Professional Overview
Raj Punwaney is an accomplished pharmaceutical and biotechnology executive with extensive experience in clinical development and business leadership. As the Vice President of Clinical Development at Alumis, he oversees the strategic planning and execution of critical clinical trials, driving the advancement of innovative therapies. Raj also maintains an active role as a Physician Volunteer at the Fleischer Institute for Diabetes & Metabolism, where he leverages his medical expertise to contribute to groundbreaking research and patient care.
Current Role
In his current role as Vice President of Clinical Development at Alumis, Raj is responsible for leading the company's clinical development strategy and ensuring the successful execution of clinical trials. He collaborates closely with cross-functional teams to design and implement efficient study protocols, manage clinical operations, and oversee data analysis and reporting. Raj's leadership has been instrumental in advancing Alumis' pipeline, with several promising drug candidates progressing through clinical development under his guidance.
Career Progression
Raj's impressive career trajectory includes senior-level positions at leading pharmaceutical and biotechnology organizations. Prior to joining Alumis, he served as the Vice President of Clinical Development at Roivant Sciences, where he played a pivotal role in the advancement of novel therapies for various disease indications. Earlier in his career, Raj held the role of Director of Clinical Development at GlaxoSmithKline, where he contributed to the successful development and regulatory approval of several high-impact products.
Academic Background
Raj Punwaney holds a medical degree from a prestigious institution, having completed his Residency in Internal Medicine and Pediatrics at Saint Vincent's Hospital in Manhattan. This extensive medical training has provided him with a deep understanding of the clinical landscape and the unique challenges faced by healthcare providers, which he leverages to drive more informed and patient-centric drug development initiatives.
Areas of Expertise
Raj's areas of expertise span the pharmaceutical and biotechnology sectors, with a particular focus on clinical development, regulatory strategy, and business leadership. He possesses a strong track record in designing and executing complex clinical trials, navigating the regulatory landscape, and collaborating with cross-functional teams to accelerate the development of innovative treatments. Raj's leadership skills, coupled with his technical expertise, have been instrumental in driving positive outcomes for the organizations he has served.
Professional Impact
Throughout his career, Raj has made significant contributions to the advancement of promising therapies in various disease areas. His leadership and strategic vision have been instrumental in the successful progression of several clinical programs, ultimately benefiting patients in need. In addition to his work at Alumis, Raj's involvement as an Adjunct Lecturer at the Zicklin School of Business and as a member of the Board of Directors at Evaeon Life Technology, Ltd. further demonstrate his commitment to driving innovation and fostering the next generation of industry leaders.
Conclusion
With his extensive experience, proven track record of success, and unwavering commitment to advancing patient-centric treatments, Raj Punwaney is a highly respected and influential leader in the pharmaceutical and biotechnology industry. As he continues to excel in his role at Alumis, he remains focused on driving meaningful progress in the development of transformative therapies that have the potential to improve the lives of those affected by complex medical conditions.
